Cureline Global Translational CRO

Cureline is a global translational and precision medicine CRO focused on human biospecimen procurement, biobanking, histopathology, molecular biology, biomarker research, and related laboratory services for biopharma and academic customers. The company built its business around ethically sourced, clinically characterized human samples and associated analytical services that support drug discovery, translational research, companion diagnostics, and assay development. Its offerings include biospecimen collection and storage, digital pathology, molecular and cell biology services, target validation, primary cell and tissue-based studies, and glycoproteomics-enabled biomarker work. Cureline has supported oncology, hematology, inflammation, neurology, infectious disease, cardiovascular, metabolic, gynecologic, dermatologic, and maternal health programs through a broad international clinical network. In January 2026, Cureline was acquired by ABS Bio, which positioned the business as part of a larger biospecimen and research services platform.